Page 1260 - Small Animal Internal Medicine, 6th Edition
P. 1260

1232   PART XI   Immune-Mediated Disorders



                   BOX 73.1
  VetBooks.ir  Infectious Diseases Implicated as Causing IMHA in Dogs
            and Cats
             Dogs
             Dirofilariasis
             Hemotrophic mycoplasmosis
             Ehrlichia canis infection
             Anaplasma phagocytophilum infection
             Leishmaniasis
             Babesiosis
             Chronic bacterial infection

             Cats
             Hemotrophic mycoplasmosis
             Feline infectious peritonitis                               A
             Feline leukemia virus
             Chronic bacterial infection

            IMHA, Immune-mediated hemolytic anemia.



                   BOX 73.2

            Dog Breeds at Increased Risk of IMHA
             Cocker Spaniel
             Bichon Frise
             Miniature Pinscher                                          B
             Miniature Schnauzer
             English Springer Spaniel                            FIG 73.1
             Rough-coated Collie                                 Mixed-breed dog with moderate icterus of the sclera (A)
             Finnish Spitz                                       and the oral mucous membranes (B).

            IMHA, Immune-mediated hemolytic anemia.



            Clinical Features
            Dogs with primary IMHA are typically young to middle-
            aged adults, with a reported age range of 1 to 13 years and a
            median age of 6 years. Females and neutered dogs of both
            sexes appear predisposed compared with sexually intact
            male dogs, and several breeds are overrepresented (see Box
            73.2). Common clinical signs of IMHA are listed in Box 73.3.
            The duration of clinical signs before presentation to the vet-
            erinary hospital is typically short, with a median of 4 days.
            Seasonal increases in diagnosis of IMHA have been reported,
            although the findings are not consistent among studies. The
            majority of reports suggest an increased frequency of IMHA
            during the warmer months of the year.
            Diagnosis
            Diagnosis of IMHA relies on identifying abnormalities con-
            sistent with hemolytic anemia on a complete blood count
            (CBC), serum biochemistry panel, and urinalysis (Box 73.4)   FIG 73.2
                                                                 Photomicrograph of a blood smear demonstrating presence
            followed by identification of antibodies directed against the   of spherocytes.
            RBC membrane. Further diagnostic testing is then directed
   1255   1256   1257   1258   1259   1260   1261   1262   1263   1264   1265